Jan Egberts - Photocure Chairman of the Board

PHO Stock  NOK 55.90  1.20  2.10%   

Chairman

Dr. Jan H. Egberts, M.D. was Chairman of the Board at Photocure ASA since April 27, 2017. Dr. Egberts has over 25 years of experience in the pharmaceutical and medical devices sector. Currently, Dr. Egberts serves as the Managing Partner of Veritas Investments, a private investment company focused on minority and controlling investments in healthcare companies. Dr. Egberts gained his medical degree from Erasmus University Medical School in the Netherlands and pursued the clinical part of his medical training at Harvard Medical School. Dr. Egberts also obtained an MBA from Stanford University. After Stanford, he joined McKinsey Co. as a strategic consultant in New York. Dr. Egberts subsequently held various business development and general management positions of increasing responsibility in the USA at Merck Co. and Johnson Johnson. While at JJ, he initiated and subsequently led the leveraged buyout of the BARRIER surgical drapes and gowns business from JJ and the subsequent merger with Mlnlycke Health Care. Thereafter, he served as Senior Advisor, Healthcare Investments for 3i, the private equity firm. Dr. Egberts then became CEO of OctoPlus, a publicly traded specialty pharmaceutical company in the Netherlands. OctoPlus was subsequently acquired by Dr Reddy Laboratories. After this, Dr. Egberts joined Agendia, a molecular diagnostics company, initially as board member and subsequently full time as interim CEO. Dr. Egberts also has held over 15 executive and nonexecutive supervisory board positions in the U.S.A. and various European countries. since 2017.
Age 59
Tenure 7 years
Phone(47) 22 06 22 18
Webwww.photocure.no

Photocure Management Efficiency

The company has return on total asset (ROA) of (0.0309) % which means that it has lost $0.0309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1567) %, meaning that it generated substantial loss on money invested by shareholders. Photocure's management efficiency ratios could be used to measure how well Photocure manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 12.5 M in total debt with debt to equity ratio (D/E) of 5.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Photocure has a current ratio of 2.98, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Photocure until it has trouble settling it off, either with new capital or with free cash flow. So, Photocure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Photocure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Photocure to invest in growth at high rates of return. When we think about Photocure's use of debt, we should always consider it together with cash and equity.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people. Photocure (PHO) is traded on Oslo Stock Exchange in Norway and employs 97 people.

Management Performance

Photocure Leadership Team

Elected by the shareholders, the Photocure's board of directors comprises two types of representatives: Photocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Photocure. The board's role is to monitor Photocure's management team and ensure that shareholders' interests are well served. Photocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Photocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Deardorff, COO
Jan Egberts, Chairman of the Board
Tolv Hillestad, Group Controller
Einar Antonsen, Director
Patricia Kelly, VP HR
Jeremy Bahr, Chief Business Officer
David Moskowitz, Head Relations
Grete Hogstad, Vice President of Strategic Marketing
Tove Ringvold, Director
Anders Neijber, Clinical Affairs
Geoffrey Coy, VP Operations
Synne Roine, Director
Erik Dahl, Chief Officer
Xavier Yon, Director
Johanna Holldack, Director
Kari MD, Head Devel
Gwen Mellincoff, Director
Ambaw Bellete, Head of United States Cancer Commercial Operations
Espen Njastein, Head of Nordic Cancer Commercial Operations
BenteLill Romoren, Chairman of the Board
Lars Ronn, Director
Kjetil Hestdal, President CEO
Gry Stensrud, VP of Technical Devel. and Operations
Daniel Schneider, President CEO
Grannum Sant, Director
Inger Heglund, Vice President of Research and Development
Tom Pike, Director

Photocure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Photocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Photocure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Photocure's short interest history, or implied volatility extrapolated from Photocure options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Photocure using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Photocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Photocure Stock analysis

When running Photocure's price analysis, check to measure Photocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Photocure is operating at the current time. Most of Photocure's value examination focuses on studying past and present price action to predict the probability of Photocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Photocure's price. Additionally, you may evaluate how the addition of Photocure to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Please note, there is a significant difference between Photocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Photocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Photocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.